This second chapter of a five-part series shows how the search for predictive biomarkers could change drug development research. The previous chapter discussed why scientific developments and recent ...

The mission of the OTI office is to nurture the changing culture of biomedical research, providing tools and resources to help academic researchers navigate the world of entrepreneurship. There are ...

The COVID-19 pandemic, along with advancements in new therapeutics and mRNA vaccines, has further intensified the need for knowledgeable professionals in the fields of immunology, microbiology, and ...

For many people, artificial intelligence is the next big thing. For Brennan Flannery, it’s a life-saving thing. As a Ph.D. candidate in Case Western Reserve University’s Department of Biomedical ...

Precision medicine approaches are rapidly transforming neuroscience, driven by advances in genetics, neuroimaging, biomarkers, and data science. These tools enable more refined disease classification, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Wake Forest University School of Medicine’s Clinical and ...

What is the work you’re leading at Takeda? Right now, we’re in the middle of building a precision and translational medicine organization for both oncology and cell therapy. I joined Takeda about a ...

Nov 28, 2022, New York---Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI) driven drug discovery company, announces that the company has appointed Dr. Man Zhang as Vice ...

Due to advancements in genetic engineering, small animal models are continuing to change in response to market needs. Model developers strive to better reflect the role of this important asset in both ...